165 related articles for article (PubMed ID: 18292829)
1. Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer.
Kanczuga-Koda L; Sulkowska M; Koda M; Rutkowski R; Sulkowski S
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S175-80. PubMed ID: 18292829
[TBL] [Abstract][Full Text] [Related]
2. Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis.
Kanczuga-Koda L; Koda M; Sulkowski S; Wincewicz A; Zalewski B; Sulkowska M
In Vivo; 2010; 24(1):101-7. PubMed ID: 20133984
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.
Kanczuga-Koda L; Sulkowski S; Lenczewski A; Koda M; Wincewicz A; Baltaziak M; Sulkowska M
J Clin Pathol; 2006 Apr; 59(4):429-33. PubMed ID: 16567471
[TBL] [Abstract][Full Text] [Related]
4. [Decreased expression of Cx32 and Cx43 and their function of gap junction intercellular communication in gastric cancer].
Wu J; Zhou HF; Wang CH; Zhang B; Liu D; Wang W; Sui GJ
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):742-7. PubMed ID: 18396685
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer.
Conklin C; Huntsman D; Yorida E; Makretsov N; Turbin D; Bechberger JF; Sin WC; Naus CC
Cancer Lett; 2007 Oct; 255(2):284-94. PubMed ID: 17583422
[TBL] [Abstract][Full Text] [Related]
6. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.
Lu LS; Chen L; Ding WX; Li K; Wu JJ
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2037-43. PubMed ID: 23280016
[TBL] [Abstract][Full Text] [Related]
9. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
[TBL] [Abstract][Full Text] [Related]
10. Suppression of human prostate cancer cell growth by forced expression of connexin genes.
Mehta PP; Perez-Stable C; Nadji M; Mian M; Asotra K; Roos BA
Dev Genet; 1999; 24(1-2):91-110. PubMed ID: 10079514
[TBL] [Abstract][Full Text] [Related]
11. Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.
Lialiaris TS; Kouskoukis A; Georgiou G; Tripsianis G; Fiska A; Giatromanolaki A; Chrisafi S; Sivridis E; Vamvakopoulou DN; Soutopoulou DO; Kiritsaka A; Athanassiou E; Lialios GA; Sotiriou S; Sidiropoulos A; Vamvakopoulos NC
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):106-11. PubMed ID: 20724920
[TBL] [Abstract][Full Text] [Related]
12. Connexin 32 induces pro-tumorigenic features in MCF10A normal breast cells and MDA-MB-231 metastatic breast cancer cells.
Adak A; Unal YC; Yucel S; Vural Z; Turan FB; Yalcin-Ozuysal O; Ozcivici E; Mese G
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118851. PubMed ID: 32918981
[TBL] [Abstract][Full Text] [Related]
13. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
[TBL] [Abstract][Full Text] [Related]
14. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the expression of phosphorylated heat shock protein beta-1 with lymph node metastases of breast cancer.
Kaigorodova EV; Zavyalova MV; Bogatyuk MV; Tarabanovskaya NA; Slonimskaya EM; Perelmuter VM
Cancer Biomark; 2015; 15(2):143-50. PubMed ID: 25519015
[TBL] [Abstract][Full Text] [Related]
16. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
[TBL] [Abstract][Full Text] [Related]
17. Expression of retinoblastoma protein in breast cancer metastases to sentinel nodes: evaluation of its role as a marker for the presence of metastases in non-sentinel axillary nodes, and comparison to p16INK4a.
Grupka NL; Bloom C; Singh M
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):63-70. PubMed ID: 16540733
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
[TBL] [Abstract][Full Text] [Related]
20. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
